SCHEMBL5592136

SCHEMBL5592136

O=S(=O)(Cl)c1ncc(C(F)(F)F)cc1Cl

nearest known ligand 0.63

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.63
HTT P42858 4/20 0.63
LMNA P02545 4/20 0.63
MAPT P10636 2/20 0.63
L3MBTL1 Q9Y468 1/20 0.49
KMT2A Q03164 4/20 0.48
POLB P06746 3/20 0.47
MEN1 O00255 2/20 0.47
TDP1 Q9NUW8 1/20 0.46
KDM4E B2RXH2 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
PLAU P00749 1/20 0.45
GAA P10253 1/20 0.44
GLA P06280 1/20 0.44
HPGD P15428 1/20 0.44
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
MAPK1 P28482 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30567082 0.86 ALDH1A1 (0.63) ALDH1A1HTTLMNAMAPTL3MBTL1
SCHEMBL6466443 0.86 ALDH1A1 (0.63) ALDH1A1HTTLMNAMAPTL3MBTL1
SCHEMBL25374549 0.86 ALDH1A1 (0.63) ALDH1A1HTTLMNAMAPTL3MBTL1
SCHEMBL21800166 0.84 ALDH1A1 (0.61) ALDH1A1HTTLMNAMAPTL3MBTL1
SCHEMBL5819225 0.84 ALDH1A1 (0.61) ALDH1A1HTTLMNAMAPTL3MBTL1
SCHEMBL8431899 0.84 ALDH1A1 (0.61) ALDH1A1HTTLMNAMAPTL3MBTL1
SCHEMBL8431893 0.83 ALDH1A1 (0.60) ALDH1A1HTTLMNAMAPTL3MBTL1
SCHEMBL9207207 0.81 ALDH1A1 (0.58) ALDH1A1HTTLMNAMAPTL3MBTL1
SCHEMBL3016113 0.80 ALDH1A1 (0.60) ALDH1A1HTTLMNAMAPTL3MBTL1
SCHEMBL7675096 0.78 ALDH1A1 (0.55) ALDH1A1HTTLMNAMAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007125398-A2 : SULFONAMIDE COMPOUNDS AS ANTAGONISTS OF THE N-TYPE CALCIUM CHANNEL PFIZER JAPAN INC. (JP) 2007-11-08 WO disclosed